Chief Legal Officer · IDEAYA Biosciences, Inc. (IDYA)

Douglas Snyder

FY2025 is the first fiscal year CompBrief holds for Douglas Snyder as a named executive officer of IDEAYA Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,131,560

6th of 6 named executive officers at Ideaya Biosciences by FY2025 total.

6 named officers on file for IDEAYA Biosciences, FY2025

See an example →

What this number hides

The filing gives the total. IDEAYA Biosciences’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how IDEAYA Biosciences’s whole pay program stands against its peers

  • IDEAYA Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IDYA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2026 (DEF 14A).

Free

Get Douglas Snyder’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Douglas Snyder and every company like it: Velarion Intel, free for 3 days, no card →

Douglas Snyder compensation by year

IDEAYA Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as IDEAYA Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$440,000
Bonus$0
Stock awards$0
Option awards$463,036
Non-equity incentive$164,000
Pension and deferred compensation$0
All other$64,523
Total$1,131,560

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IDEAYA Biosciences, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191501, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IDEAYA Biosciences, Inc. filed document, accession 0001193125-26-191501. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option96,251—$30.50
Option33,000—$20.24

Per the Outstanding Equity Awards at Fiscal Year-End table in IDEAYA Biosciences, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

IDEAYA Biosciences’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Yujiro HataPresident, Chief Executive Officer and Director$9,512,640
Joshua BleharskiChief Financial Officer$4,147,322
Darrin BeaupreChief Medical Officer$3,334,109
Michael WhiteChief Scientific Officer$3,324,109
Andres Ruiz BrisenoChief Accounting Officer$1,653,155
Douglas Snyder · this pageChief Legal Officer$1,131,560

Douglas Snyder's compensation dossier, IDEAYA Biosciences

You have read Douglas Snyder's totals and holdings. The dossier adds each equity grant IDEAYA Biosciences disclosed for Douglas Snyder and IDEAYA Biosciences's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full IDEAYA Biosciences compensation record

free company brief

This page is one person within IDEAYA Biosciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IDEAYA Biosciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order IDEAYA Biosciences's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IDEAYA Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order IDYA

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Douglas Snyder's compensation dossier